The Australian Financial Complaints Authority has published amendments to its Rules, effective Oct. 8, 2026, enabling it to consider complaints about life insurers soliciting or using adverse genetic testing results. The Australian Securities and Investments Commission approved the final changes, which align AFCA’s jurisdiction with recent legislative protections for genetic information in life insurance. The amendments to Rules C.1.4 b and d follow AFCA’s June 2026 consultation. AFCA has also published updated Operational Guidelines, its response to feedback, nonconfidential submissions and the consultation response paper.